Bruce Dalton

599 total citations
29 papers, 385 citations indexed

About

Bruce Dalton is a scholar working on Infectious Diseases, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Bruce Dalton has authored 29 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Pharmacology and 8 papers in Clinical Biochemistry. Recurrent topics in Bruce Dalton's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Use and Resistance (8 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Bruce Dalton is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Use and Resistance (8 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Bruce Dalton collaborates with scholars based in Canada, United States and Australia. Bruce Dalton's co-authors include Thomas Louie, Deana Sabuda, Kevin B. Laupland, Johann Pitout, Duncan MacCannell, Elizabeth A. Henderson, John Conly, Daniel B. Gregson, Terry Ross and Vikas P. Chaubey and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Transplantation.

In The Last Decade

Bruce Dalton

25 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce Dalton Canada	11	148	139	127	102	65	29	385
Amira A. Bhalodi United States	9	152 1.0×	161 1.2×	88 0.7×	108 1.1×	101 1.6×	18	381
Csaba Fehér Spain	14	119 0.8×	157 1.1×	190 1.5×	180 1.8×	96 1.5×	23	482
Sabrina Khan United States	8	140 0.9×	135 1.0×	161 1.3×	204 2.0×	50 0.8×	10	513
Athena L V Hobbs United States	10	93 0.6×	121 0.9×	129 1.0×	65 0.6×	47 0.7×	31	355
Jessica S Tischendorf United States	7	96 0.6×	49 0.4×	123 1.0×	183 1.8×	55 0.8×	17	371
Monique R. Bidell United States	13	262 1.8×	157 1.1×	167 1.3×	134 1.3×	72 1.1×	26	607
Frédérique Bouchand France	15	211 1.4×	63 0.5×	214 1.7×	144 1.4×	50 0.8×	52	603
Jaye Weston United States	9	134 0.9×	98 0.7×	159 1.3×	206 2.0×	74 1.1×	12	564
Laura Whitney United Kingdom	8	189 1.3×	55 0.4×	132 1.0×	48 0.5×	67 1.0×	18	395
Myrto Eleni Flokas United States	13	147 1.0×	76 0.5×	235 1.9×	209 2.0×	123 1.9×	20	605

Countries citing papers authored by Bruce Dalton

Since Specialization

Citations

This map shows the geographic impact of Bruce Dalton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Dalton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Dalton more than expected).

Fields of papers citing papers by Bruce Dalton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Dalton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Dalton. The network helps show where Bruce Dalton may publish in the future.

Co-authorship network of co-authors of Bruce Dalton

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Dalton. A scholar is included among the top collaborators of Bruce Dalton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Dalton. Bruce Dalton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doyle, D. John, Bruce Dalton, Deana Sabuda, et al.. (2024). A quasi-experimental analysis comparing antimicrobial usage on COVID-19 and non-COVID-19 wards. SHILAP Revista de lepidopterología. 4(1). e192–e192.

Bresee, Lauren, Jayna Holroyd‐Leduc, Deana Sabuda, et al.. (2023). Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection. BMC Health Services Research. 23(1). 1386–1386. 2 indexed citations

Lam, John C., Deirdre L. Church, Julie Carson, et al.. (2023). Incidence, susceptibility and outcomes of candidemia in adults living in Calgary, Alberta, Canada (2010–2018). BMC Infectious Diseases. 23(1). 100–100. 10 indexed citations

Dalton, Bruce. (2023). What Is the Best Vancomycin Therapeutic Drug Monitoring Parameter to Assess Efficacy? A Critical Review of Experimental Data and Assessment of the Need for Individual Patient Minimum Inhibitory Concentration Value. Microorganisms. 11(3). 567–567. 4 indexed citations

Jorgensen, Sarah C J, Deonne Dersch‐Mills, Kathryn Timberlake, et al.. (2021). AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatrics. Journal of Antimicrobial Chemotherapy. 76(9). 2237–2251. 14 indexed citations

Jorgensen, Sarah C J, et al.. (2020). Vancomycin AUC-guided therapeutic drug monitoring to reduce nephrotoxicity: are we overlooking a simpler solution? Comment on: Oda K, Jono H, Nosaka K, Saito H. Reduced nephrotoxicity in vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against trough 15–20 µg/mL concentration.. International Journal of Antimicrobial Agents. 56(5). 106150–106150. 4 indexed citations

Dalton, Bruce, et al.. (2019). Vancomycin area under the curve to minimum inhibitory concentration ratio predicting clinical outcome: a systematic review and meta-analysis with pooled sensitivity and specificity. Clinical Microbiology and Infection. 26(4). 436–446. 46 indexed citations

Dalton, Bruce, Lauren Bresee, Nipunie Rajapakse, et al.. (2015). Antimicrobial Use Over a Four‐Year Period Using Days of Therapy Measurement at a Canadian Pediatric Acute Care Hospital. Canadian Journal of Infectious Diseases and Medical Microbiology. 26(5). 253–258. 16 indexed citations

Dalton, Bruce, et al.. (2015). Histiocytoid Variant of Sweet Syndrome Associated with Azacitidine and Recurrence upon Rechallenge. The Canadian Journal of Hospital Pharmacy. 68(4). 339–41. 6 indexed citations

10.

Dalton, Bruce, Deana Sabuda, Lauren Bresee, & John Conly. (2015). Use of an Electronic Medication Administration Record (eMAR) for Surveillance of Medication Omissions: Results of a One Year Study of Antimicrobials in the Inpatient Setting. PLoS ONE. 10(4). e0122422–e0122422. 10 indexed citations

11.

Dalton, Bruce, Deana Sabuda, Lauren Bresee, & John Conly. (2015). Assessment of Antimicrobial Utilization Metrics: Days of Therapy Versus Defined Daily Doses and Pharmacy Dispensing Records Versus Nursing Administration Data. Infection Control and Hospital Epidemiology. 36(6). 688–694. 12 indexed citations

12.

Dalton, Bruce, et al.. (2015). Surveillance of Antimicrobial Utilization at Five Neonatal Intensive Care Units in an Urban Centre in Alberta, Canada. Open Forum Infectious Diseases. 2(suppl_1).

13.

Chaubey, Vikas P., Johann Pitout, Bruce Dalton, et al.. (2014). Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region. BMC Infectious Diseases. 14(1). 647–647. 29 indexed citations

14.

Dalton, Bruce, et al.. (2013). Venous Thromboembolism Due to Suspected Interaction Between Nevirapine and Rivaroxaban. The Canadian Journal of Hospital Pharmacy. 66(2). 125–9. 22 indexed citations

15.

Dalton, Bruce, et al.. (2013). Extensive Necrotizing Fasciitis Associated With Sunitinib Therapy. Clinical Genitourinary Cancer. 12(2). e47–e49. 3 indexed citations

16.

Kline, Gregory, et al.. (2013). Predicting Deficiency of Vitamin D in Renal Transplant Recipients in Northern Climates. Transplantation. 95(12). 1479–1484. 12 indexed citations

17.

Dalton, Bruce, Danny J. Zuege, Reza Shahpori, & Kevin B. Laupland. (2010). Concomitant Ceftriaxone and High-Concentration Intravenous Calcium Therapy in Adult Critical Care Patients: A Matched Cohort Study. Annals of Pharmacotherapy. 44(7-8). 1158–1163. 4 indexed citations

18.

Sabuda, Deana, Kevin B. Laupland, Johann Pitout, et al.. (2008). Utilization of Colistin for Treatment of Multidrug‐Resistant Pseudomonas aeruginosa. Canadian Journal of Infectious Diseases and Medical Microbiology. 19(6). 413–418. 47 indexed citations

19.

Dalton, Bruce, et al.. (2008). Proton pump inhibitors increase significantly the risk ofClostridium difficileinfection in a low‐endemicity, non‐outbreak hospital setting. Alimentary Pharmacology & Therapeutics. 29(6). 626–634. 78 indexed citations

20.

Dalton, Bruce & Lois L. Wright. (2003). Exploring Redundancy in SocialWork Education. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact